Medicure (MCUJF) Capital Expenditures Growth (1y) (2016 - 2019)
Medicure (MCUJF) Capital Expenditures Growth (1y) (2016 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.24 Bn | 87.37 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.28 Bn | 21.13 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 20.54 Bn | 20.54 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.55 Bn | 12.12 Bn | 785.00 Mn | -21.54% |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -53.06% |
| Jun 30, 2019 | 77.04% |
| Mar 31, 2019 | -64.06% |
| Sep 30, 2018 | 98.99% |
| Jun 30, 2018 | 97.43% |
| Mar 31, 2018 | 72.12% |
| Sep 30, 2017 | -3,971.44% |
| Jun 30, 2017 | -2,255.89% |
| Mar 31, 2017 | -622.04% |
| Dec 31, 2016 | -218.41% |
| Sep 30, 2016 | 62.22% |
| Jun 30, 2016 | -64.28% |
| Mar 31, 2016 | -46.82% |